Stock & Company Details
Galectin Therapeutics Inc $GALT
Price:
N/A
N/A
101M
$357M
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.63
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GALT technical indicators
Latest Galectin Therapeutics Inc (GALT) indicator readings as of 2026-10-29.
GALT's 14-day RSI is 46.9, in neutral territory. At $3.52 it is trading 9.8% above its 200-day moving average of $3.21, and below its 50-day average of $3.82. Price sits in the middle of its Bollinger Bands ($3.16 to $4.00). ADX reads 20.3, sitting between trending and range-bound.
Overview
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Finance Bot
Ask your questions
Start by typing a question below.
